Allogene Reports Patient Death Linked to ALLO-647 Conditioning Antibody in CAR-T Trial on August 04, 2025 Adenovirus Infections Allogene ALPHA3 trial Anti-CD52 Monoclonal Antibody ALLO-647 CAR-T Liver Failure Lymphodepletion Therapy Monoclonal Antibodies Patient Death +
FDA Threatens Action After Sarepta Refuses to Halt Elevidys Shipments on July 21, 2025 Elevidys gene therapy Liver Failure Market Muscular Dystrophy, Duchenne patient deaths Regulatory Authority United States Food and Drug Administration Withdraw (activity) +
Sarepta Reports Death of DMD Patient Following Elevidys Gene Therapy Treatment on March 19, 2025 acute Duchenne Elevidys gene therapy Liver Failure Muscular Dystrophy +